The Story of Taxol
Nature and Politics in the Pursuit of an Anti-Cancer Drug
- Publisher's listprice GBP 57.99
-
29 348 Ft (27 951 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 5 870 Ft off)
- Discounted price 23 479 Ft (22 361 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
29 348 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Cambridge University Press
- Date of Publication 5 March 2001
- ISBN 9780521561235
- Binding Hardback
- No. of pages298 pages
- Size 238x161x24 mm
- Weight 528 g
- Language English
- Illustrations 8 b/w illus. 0
Categories
Short description:
The story of taxol; arguably the most celebrated and controversial natural product in recent years.
MoreLong description:
Taxol is arguably the most celebrated, talked-about and controversial natural product in recent years. It is celebrated because of its efficacy as an anti-cancer drug and because its discovery has provided powerful support for policies concerned with biodiversity; talked about because in the late 1980s and early 1990s the American public was bombarded with news reports and special programmes about the molecule and its host, the Pacific yew; and controversial because during the early 1990s the drug and the tree became embroiled in a number of very sensitive political issues with wide implications for the conduct of public policy. The Story of Taxol tells this story.
'It is carefully researched and detailed, and as someone who was at the National Cancer Institute (NCI) during part of the development of Taxol, I found it factually accurate.' Vincent T. DeVita, Jr, New England Journal of Medicine
Table of Contents:
Acknowledgements; Abbreviations; Introduction; Part I. Agents: 1. Cancer chemotherapy: plant knowledge and practice; Part II. Practices: 2. Act I: 1962-75; 3. Act II: 1976-83; 4. Act III: 1984-9; Part III. Controversies: 5. The politics of exclusivity and the business of taxol; 6. The political life (and death) of Taxus Brevifolia; References and bibliography; Index.
More
